Focus: Athena Bioscience is a specialty pharmaceutical company focused on neurology-indicated treatments, with an established commercial portfolio of pain and psychiatric medications.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow Athena Bioscience to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Long patent tail (16+ years) provides sustained revenue runway; opioid indication in mature pain market.
Help build intelligence for Athena Bioscience
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Athena Bioscience's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Multi-indication neuropsych asset with 7+ year exclusivity window; addresses high-demand ADHD market segment.
Nearing patent expiration (3 years); generics erosion likely; downstream impact on revenue and staffing.
2 discontinued, 0 duplicate formulations not shown
No open positions listed yet.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moSource: USCIS H-1B Employer Data Hub
Source: state DOL filings, aggregated via Big Local News
No major compliance or supply-chain red flags detected; however, zero pipeline combined with patent cliffs creates structural vulnerability.